(Q74283605)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

N Shimma

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

I Umeda

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Arasaki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

C Murasaki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

K Masubuchi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Y Kohchi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Miwa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Ura

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

N Sawada

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

H Tahara

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

I Kuruma

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

I Horii

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

H Ishitsuka

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

Bioorganic & Medicinal Chemistry

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

1697-1706

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a regimen. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900087-0

7 January 2021

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900087-0

7 January 2021

Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900087-0

7 January 2021

Studies of the enzymatic deamination of cytosine arabinoside. I. Enzyme distribution and species specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900087-0

7 January 2021

Purification and properties of cytidine deaminase from normal and leukemic granulocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900087-0

7 January 2021

Comparative antitumor activity and intestinal toxicity of 5'-deoxy-5-fluorouridine and its prodrug trimethoxybenzoyl-5'-deoxy-5-fluorocytidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900087-0

7 January 2021

A general synthesis of N-glycosides. I. Synthesis of pyrimidine nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900087-0

7 January 2021

Synthetic nucleosides and nucleotides. XI. Facile synthesis and antitumor activities of various 5-fluoropyrimidine nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900087-0

7 January 2021

Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900087-0

7 January 2021

Antitumor activities of a novel fluoropyrimidine, N4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine (capecitabine)

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900087-0

7 January 2021

Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900087-0

7 January 2021

Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900087-0

7 January 2021

10.1016/S0968-0896(00)00087-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10976516%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference